Aclaris Therapeutics, Inc.

Symbol: 0H8T.L

LSE

1.17

USD

Market price today

  • -0.9383

    P/E Ratio

  • -0.0231

    PEG Ratio

  • 83.38M

    MRK Cap

  • 0.00%

    DIV Yield

Aclaris Therapeutics, Inc. (0H8T-L) Stock Split, History Data

Working capital analysis

In terms of working capital, Aclaris Therapeutics, Inc. maintains a healthy position. The total current assets of the company are valued at $128856000. This represents a growth rate of -44.351% compared to the previous year. Breaking down the current assets, the cash and investments are worth $39878000, exhibiting a growth rate of -11.924% year-on-year. The receivables, another significant portion of the current assets, are valued at $298000. The year-on-year growth rate for receivables is -38.430%. On the liabilities side, the company's current liabilities total $30952000. This reflects a growth rate of 41.089% over the previous year, indicating the company's financial obligations are well under control.

202320222021202020192018
Cash and investments
39.88
45.28
27.35
22.06
35.94
57.02
Receavebles
0.30
0.48
0.62
0.77
0.70
0.56
Inventory
0.00
0.00
0.00
0.00
0.00
0.00
Other
9.45
13.49
12.99
2.59
8.08
10.96
Total Current Assets
128.86
231.55
205.03
57.49
83.80
179.50
Acc Payable
8.88
10.35
9.98
5.25
9.92
11.68
Short Term Debt
0.43
0.68
0.69
0.60
0.64
0.00
Other Current Liab
21.65
10.90
12.25
9.02
11.88
15.67
Current Liabilities
30.95
21.94
22.93
14.87
22.43
27.34

Capital Structure

When examining the capital structure of Aclaris Therapeutics, Inc., it is clear that the company manages a robust portfolio. The value of their total assets clocks in at $174065000. When juxtaposed with the previous year, this marks a growth rate of -24.222%, showcasing the company's ability to steadily grow its asset base. Turning to liabilities, the company has total liabilities amounting to $32051000. Compared to the prior year, this reflects a growth rate of -39.406%. The long-term debt forms a sizable part of these liabilities, coming in at $2971000. Over the last year, the long-term debt has grown by 50.812%. On the asset side, the cash and equivalent reserves are worth $35841000. The year-on-year growth of these reserves is -19.858%. The company's common stock, another important asset, holds a value of $1000, growing at a rate of 0.000% from the previous year. Finally, the company's retained earnings stand at $-787737000, marking a growth rate of 10.875% year-over-year. These earnings represent the profits that Aclaris Therapeutics, Inc. has chosen to reinvest in the business rather than distribute as dividends.

Total Assets

$174.06

Total liabilities

$32,051,000.00

Long term debt

$2.97

Cash and eqv

$35,841,000.00

Goodwill

$0.00

Retained earnings

-$787,737,000.00

Common stock

$0.00

Enterprise Value

-$1.22

Net earnings per share (EPS)

Aclaris Therapeutics, Inc. has an EPS of $-0.24, which signifies the profit allocated per share of common stock. With a growth rate of 81.117% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.

YearsQ1Q2Q3Q4Total
2024-0.24----0.24
2023-0.42-0.42-0.41-0.021-1.27
2022-0.31-0.31-0.3-0.41-1.33
2021-0.57-0.34-0.35-0.37-1.63
2020-0.37-0.27-0.25-0.31-1.20
2019-0.66-1.06-0.56-0.47-2.75
2018-0.98-0.25-0.67-0.61-2.51
2017-0.48-0.56-0.63-0.74-2.41
2016-0.65-0.62-0.5-0.49-2.26
2015-1.61-1.52-5.12-0.28-8.53
2014-1.25-1.25-1.75-1.76-6.01

Frequently Asked Question

What is the latest historical split date of the company?

The latest historical split date is N/A.

What is firm free cah flow per share (FCF per share)?

The free cah flow per share (FCF per share) is -1.037.

What is company revenue per share?

The company revenue per share is -2.878.

What are firm earnings per share?

The firm earnings per share is 0.995.

What is Aclaris Therapeutics, Inc. (0H8T.L) ROIC (return on capital)?

Aclaris Therapeutics, Inc. (0H8T.L) ROIC (return on capital) is -0.582.

What is dividend per share figure?

The dividend per share is 0.000

What is enterprise plowback ratio?

Aclaris Therapeutics, Inc. (0H8T.L) plowback ratio is N/A

What is firm enterprise value (EV)?

The enterprise value (EV) is -1.217

What is company debt to equity ratio?

The debt to equity ratio is 0.024

What are debt ratio numbers?

The debt ratio is 0.020

What is company price to sales ratio?

The price to sales ratio is 2.427